Cobra has established a range of cell-based and enzymatic bioassays to quantify the potency of biomolecules. We provide a one-stop service from bioassay development to cGMP batch-release testing, and can advise on the best route for developing an assay for a customers’ product.
The end-point in the bioassay is determined by the mode of action of the customer’s drug.
Cobra’s Bioassay team has broad cell culture and cGMP analytical experience and, depending on the requirement for formal data review, our Quality Assurance department or Quality Control function provides study data audits after the laboratory phase of the work has been completed.
If you would like any further information, please don't hesitate to get in touch